The pharmaceutical sector is the field with the best chance of receiving funds from the technology sector. The technology sector is still very strong, just like the previous major topic of medical beauty, but we must clearly understand one key point, that is The technology sector has been around for a while, and many branches in it have been pulled through. It is similar to the previous medical aesthetics. Medical aesthetics also starts to organize the outflow of funds after the branches are completed. After the funds flow out, they will look for new ones. hot opportunity sector. Zhongheng Group
Traditional Chinese medicine manufacturing is the core leading industry of Zhongheng Group. After nearly fifty years of development, it is now a modern comprehensive high-tech pharmaceutical enterprise and plays a decisive role in the domestic traditional Chinese medicine manufacturing industry. The company has rich product resources and strong technical force. It has unique advantages in the fields of bruises, cardiovascular and cerebrovascular diseases, and gynecology using the theory of traditional Chinese medicine research and development.
We have mastered a large number of pharmaceutical technologies with independent intellectual property rights and a complete set of mature product production processes. In particular, our achievements in the extraction technology of active ingredients of traditional Chinese medicine monomers are in a leading position in the country. The two main products of Zhonghua Dieda Pills and Fuyanjing Capsules have obtained national invention patents, and many products such as Xueshuantong for Injection and Calculus Tong Tablets have been rated as high-tech products. Fosun Pharma
Fosun Pharma is a Shanghai private enterprise listed in 1998. It was founded in 1992 by four Fudan graduates. It is the predecessor of Fosun Group and is now affiliated with Fosun Group. Its business areas cover Pharmaceutical industry, pharmaceutical business, diagnostic reagents, medical equipment. Net profit and net assets rank third among listed pharmaceutical companies in China. At the same time, Fosun Pharma is also an excellent company that is good at investment, with good development prospects and strong company strength.
After the company’s first biosimilar drug rituximab was launched in 2019, the company gradually entered the R&D harvest period. Currently, the approved biosimilar drug rituximab and other innovative drugs will be followed by Lulimumab, bevacizumab, etc. will be launched one after another, and the product structure will be continuously optimized. Innovative products will gradually become the main driver of the company's performance growth. The company invested in the joint venture Fosun Kite's CAR-T product Akilenza Injection, CAR-T is the first to be launched in China, and its first-mover advantage is expected to establish a leading position. Kindly
Zhejiang Kindly Medical Equipment Co., Ltd. was established in 1987. It is a manufacturer specializing in the production of medical puncture equipment series under the Kindly Group. The company integrates product research and development, production and sales. It is one of the few domestic manufacturers with a complete industrial chain of medical puncture instruments. It is a national high-tech enterprise and Zhejiang Enterprise Technology Center. It has won the titles of Zhejiang Manufacturing Quality, Zhejiang Export Famous Brand, Honorary titles such as Famous Firm in Zhejiang Province and Leading Enterprise in Wenzhou City. The company won the Wenzhou Mayor's Quality Award in 2019.
The company is mainly engaged in the research and development, production and sales of medical puncture needles, medical infusion equipment, interventional equipment and other medical devices, which are widely used in clinical applications. Based on a strong R&D platform, the company has carried out in-depth cooperation with many well-known domestic universities and scientific research units to form an integration of industry, academia and research, and currently has 47 patents of various types. With investments in various automated product production lines, intelligent sterilization systems, intelligent three-dimensional warehouses, and "intelligent manufacturing" projects, it has become a model enterprise for "machine substitution" and "integration of informatization and informatization" in the industry. Taiji Group
Taiji Group is a wholly state-owned enterprise 100% controlled by the State-owned Assets Supervision and Administration Commission of Fuling District, Chongqing City. It is a local state-owned enterprise in Fuling District, Chongqing City. "Taiji Group" among listed companies refers to Taiji Industrial Group Co., Ltd. Taiji Industrial Group is a holding subsidiary of Taiji Group, and its ultimate controlling interest also belongs to the Fuling District State-owned Assets Supervision and Administration Commission, so it is also a local state-owned enterprise in Fuling District. However, Taiji Industrial Group has non-state-owned shareholders, so it is not a wholly state-owned enterprise, but a state-owned joint-stock enterprise controlled by state-owned assets.
China Electronics Group Corporation (CETC for short) is an important state-owned enterprise approved by the State Council and established on the basis of the former electronics research institutes and high-tech enterprises directly under the Ministry of Information Industry. It is directly managed by the central government. Deputy ministerial level military industrial group. Mainly engaged in the engineering construction of large-scale national important military and civilian electronic information systems, the development and production of major equipment, communications and electronic equipment, software and key components.